2-pyrrolino-dox has been researched along with nitrophenols in 1 studies
| Studies (2-pyrrolino-dox) | Trials (2-pyrrolino-dox) | Recent Studies (post-2010) (2-pyrrolino-dox) | Studies (nitrophenols) | Trials (nitrophenols) | Recent Studies (post-2010) (nitrophenols) |
|---|---|---|---|---|---|
| 28 | 0 | 2 | 7,412 | 99 | 1,742 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagy, A; Plonowski, A; Schally, AV | 1 |
1 other study(ies) available for 2-pyrrolino-dox and nitrophenols
| Article | Year |
|---|---|
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
Topics: Adult; Animals; Antineoplastic Agents; Bombesin; Carboxylesterase; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Drug Interactions; Drug Stability; Gonadotropin-Releasing Hormone; Half-Life; Humans; Hydrolysis; Isoflurophate; Male; Mice; Mice, Nude; Nitrophenols; Paraoxon; Pyrroles; Weight Loss | 2000 |